Hennessy Advisors Inc’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Hennessy Advisors Inc’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-652,100	Closed	-$10M	–	383
2025 Q1	$10M	Sell	652,100 -74,500	-10%	-$1.33M	0.33%	81
2024 Q4	$16M	Buy	726,600 +46,300	+7%	+$842K	0.48%	51
2024 Q3	$12.3M	Buy	680,300 +76,400	+13%	+$1.34M	0.39%	59
2024 Q2	$9.81M	Buy	+603,900	New	+$9.3M	0.37%	60
2018 Q1	–	Sell	-147,300	Closed	-$2.79M	–	419
2017 Q4	$2.79M	Hold	147,300	–	–	0.09%	211
2017 Q3	$2.59M	Hold	147,300	–	–	0.08%	200
2017 Q2	$4.89M	Sell	147,300 -5,200	-3%	-$161K	0.15%	147
2017 Q1	$4.89M	Buy	+152,500	New	+$5.2M	0.14%	153

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Hennessy Advisors Inc's TEVA Position: Q2 2025 in Review

Hennessy Advisors Inc sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2025, closing a stake of 652,100 shares — an estimated $10M sold.

Hennessy Advisors Inc first reported a position in TEVA in Q1 2017 and held it in 8 quarters. The position peaked at $16M in Q4 2024. 542 funds tracked by Wall St. Rank hold TEVA as of Q2 2025.

Hennessy Advisors Inc reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2025 after selling out during the quarter.
Hennessy Advisors Inc sold 652,100 Teva Pharmaceutical Industries Limited shares in Q2 2025, an estimated $10M.
Hennessy Advisors Inc first reported a position in Teva Pharmaceutical Industries Limited in Q1 2017 and held it in 8 quarters.
Hennessy Advisors Inc's Teva Pharmaceutical Industries Limited position peaked at $16M in Q4 2024.
542 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2025.

Based on Hennessy Advisors Inc's 13F filing for Q2 2025, filed 21 Jul 2025.